• Kendall

Friedreich's Ataxia Treatment Advancement


The Friedreich's Ataxia Research Alliance announced today that BioMarin Pharmaceutical, a company with a strong commitment and success in developing treatments for rare diseases, will be taking the Histone DeACetylase (HDAC) inhibitor program forward. Click here to access FARA's press release as well as a press release from Repligen and BioMarin.

With this exciting news, we are reminded of the important work our donations fund. Thank you to everyone who has had a part in making this happen. We are moving forward to finding a cure for Friedreich's Ataxia!

#friedreichsataxia #clinicaltrials #treatment #symptoms

0 views0 comments

Recent Posts

See All

Choosing To Trust The One Who Holds Your Future

I am the "Blog Boss" for the fantastic ministry, Fearless Mom. We let moms share their unique perspectives in hopes of encouraging other moms, world-wide. I was featured on the blog and I wanted to sh

Taking Another Friedreich’s Ataxia Setback in Stride

I am a freelance columnist for Friedreich's Ataxia News. I was recently published on my column, My Darling Disability, and I wanted to share it here, too. You can either read it by following this link